Synergy between RA and TLR3 promotes type I IFN-dependent apoptosis through upregulation of TRAIL pathway in breast cancer cells.
Synergy between RA and TLR3 promotes type I IFN-dependent apoptosis through upregulation of TRAIL pathway in breast cancer cells.
复制标题
DOI:
10.1038/cddis.2013.5
复制
发表时间:
2013-01-31
影响因子:
9
通讯作者:
Jimenez-Lara, A. M.
中科院分区:
文献类型:
--
作者:
Bernardo, A. R.;Cosgaya, J. M.;Aranda, A.;Jimenez-Lara, A. M.
关键词:
Due to its ability to regulate the growth, differentiation and apoptosis of cancer cells, retinoic acid (RA) is considered a signaling molecule with promising therapeutic potential in oncology. In this study, we show that RA is able to induce the intrinsic ability of breast cancer cells to recognize double-stranded RNA (dsRNA) through the upregulation of Toll-like receptor 3 (TLR3) expression. RA, co-administered with the dsRNA mimicker polyinosinic–polycytidylic acid (poly(I:C)), synergizes to mount a specific response program able to sense dsRNA through the concurrent upregulation of TLR3, the dsRNA helicases melanoma differentiation-associated antigen-5 (MDA-5) and RA-inducible gene-1 (RIG-1), and the dsRNA-activated protein kinase (PKR) expression, leading breast cancer cells to specifically express downstream transcriptional targets of dsRNA sensors, such as interferon-β (IFNβ), interleukin-8 (IL-8), chemokine (C-C motif) ligand 5 (CCL5), and C-X-C motif Chemokine 10 (CXCL10). A TLR3-dependent apoptotic program is also induced by RA and poly(I:C) co-treatment that correlates with the induction of the tumor necrosis factor (TNF)-related apoptosis-inducing ligand (TRAIL) and contributes to block breast cancer cell proliferation. The mechanisms of apoptosis induced by RA/poly(I:C) in breast cancer cells involve type I IFN autocrine signaling, caspase-8 and caspase-3 activation, as well as TRAIL signaling. Our results reveal important links among RA, TLR3 and TRAIL and highlight the combined use of RA and poly(I:C) as a potential effective tumor therapy by improving the apoptotic response of cancer cells with low sensitivity to the action of synthetic dsRNA.
登录
查看更多内容
影响因子:
64.8
作者:
Alexopoulou, L;Holt, AC;Flavell, RA
通讯作者:
Flavell, RA
影响因子:
3.9
作者:
Jiang, Qun;Wei, Haiming;Tian, Zhigang
通讯作者:
Tian, Zhigang
影响因子:
4.8
作者:
Kolla, V;Lindner, DJ;Kalvakolanu, DV
通讯作者:
Kalvakolanu, DV
影响因子:
6.4
作者:
Chen, QY;Ma, YF;Ross, AC
通讯作者:
Ross, AC
DOI:
10.1097/ppo.0b013e3181eaca65
发表时间:
2010-07
期刊:
Cancer journal (Sudbury, Mass.)
影响因子:
--
作者:
Gnjatic S;Sawhney NB;Bhardwaj N
通讯作者:
Bhardwaj N